BAY87-2243
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY87-2243, covering 2013-07-30 to 2013-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study to Evaluate the Maximum Tolerated Dose of BAY87-2243 in Patients With Advanced Malignancies [Phase 1]